Trial intelligence / Profile preview

Levofloxacin for eradication of Helicobacter pylori infection

IRCT2015081818124N2Phase 3Completed

Sponsor
Qazvin University of Medical Sciences
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of levofloxacin in Helicobacter pylori infection, sponsored by Qazvin University of Medical Sciences. Started Feb 2015; status: completed.

02

Drugs

levofloxacin
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on IRCT2015081818124N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015081818124N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call